Table 3 Risk assessment of gene variants for neonatal hyperbilirubinemia by log-binomial analysis (n = 444)
From: Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan
Gene variant | Relative risk | 95 % CI | p value |
|---|---|---|---|
ABO incompatibility | 1.075 | 0.685–1.687 | 0.754 |
G6PD deficiency | 1.985 | 1.010–3.901 | 0.047 |
Alpha thalassemia | 0.619 | 0.252–1.519 | 0.295 |
GA at nt211 in UGT1A1 | 1.548 | 1.096–2.187 | 0.013 |
GA at nt388 in SLCO1B1 | 0.921 | 0.627–1.353 | 0.675 |
Short HO-1 promoter GT-repeat | 2.185 | 1.527–3.125 | <0.001 |